[go: up one dir, main page]

ID21650A - Suspensi farmasi yang terdiri dari nevirapin hemihidrat - Google Patents

Suspensi farmasi yang terdiri dari nevirapin hemihidrat

Info

Publication number
ID21650A
ID21650A IDP981156A ID981156A ID21650A ID 21650 A ID21650 A ID 21650A ID P981156 A IDP981156 A ID P981156A ID 981156 A ID981156 A ID 981156A ID 21650 A ID21650 A ID 21650A
Authority
ID
Indonesia
Prior art keywords
hemihidrat
nevirapin
pharmaceutical suspension
suspension consist
consist
Prior art date
Application number
IDP981156A
Other languages
English (en)
Inventor
Karl Georg Dr Grozinger
Amale Ayoub Dr Hawi
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21650(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID21650A publication Critical patent/ID21650A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP981156A 1997-08-25 1998-08-24 Suspensi farmasi yang terdiri dari nevirapin hemihidrat ID21650A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
ID21650A true ID21650A (id) 1999-07-08

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981156A ID21650A (id) 1997-08-25 1998-08-24 Suspensi farmasi yang terdiri dari nevirapin hemihidrat

Country Status (37)

Country Link
US (2) US6172059B1 (id)
EP (1) EP1019058B1 (id)
JP (1) JP3472261B2 (id)
KR (1) KR100426516B1 (id)
CN (1) CN1197578C (id)
AR (2) AR016869A1 (id)
AT (1) ATE326971T1 (id)
AU (1) AU742761B2 (id)
BG (1) BG64337B1 (id)
BR (1) BR9811994B1 (id)
CA (1) CA2301646C (id)
CL (1) CL2008003111A1 (id)
CO (1) CO4970742A1 (id)
CY (1) CY1105228T1 (id)
CZ (1) CZ290667B6 (id)
DE (1) DE69834655T2 (id)
DK (1) DK1019058T3 (id)
EG (1) EG24075A (id)
ES (1) ES2265666T3 (id)
HR (1) HRP980461B1 (id)
HU (1) HU226063B1 (id)
ID (1) ID21650A (id)
IL (1) IL134185A (id)
MY (1) MY122272A (id)
NO (1) NO326226B1 (id)
NZ (1) NZ503414A (id)
PE (1) PE105799A1 (id)
PL (1) PL192361B1 (id)
PT (1) PT1019058E (id)
RS (1) RS49808B (id)
RU (1) RU2196584C2 (id)
SA (1) SA98190680B1 (id)
TR (1) TR200000490T2 (id)
TW (1) TW450812B (id)
UA (1) UA44370C2 (id)
WO (1) WO1999009990A1 (id)
ZA (1) ZA987623B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
WO2003091290A1 (en) * 2002-04-23 2003-11-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for reduction of residual organic solvent in carbomer
AU2006286314A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
DE112010004065T5 (de) * 2009-11-10 2012-10-25 North West University Verfahren zur Erhöhung der Löslichkeit einer Transkriptaseinhibitor-Zusammensetzung
BR112012014762A2 (pt) * 2009-12-17 2016-03-29 Univ Northwest forma polimorfa de nevirapina e sua preparação

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
EP0410148B1 (en) * 1989-06-28 1994-04-06 Boehringer Ingelheim Pharmaceuticals Inc. Novel 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and thiones and their use in the prevention or treatment of AIDS
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
GB9215178D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
JP3000564B2 (ja) * 1993-12-15 2000-01-17 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
BR9811994B1 (pt) 2013-11-19
EG24075A (en) 2008-05-11
PE105799A1 (es) 1999-11-16
MY122272A (en) 2006-04-29
NO326226B1 (no) 2008-10-20
KR20010023257A (ko) 2001-03-26
DE69834655T2 (de) 2006-12-14
EP1019058A4 (en) 2004-11-10
DK1019058T3 (da) 2006-06-12
RU2196584C2 (ru) 2003-01-20
KR100426516B1 (ko) 2004-04-13
EP1019058A1 (en) 2000-07-19
HRP980461B1 (en) 2002-08-31
ZA987623B (en) 2000-03-22
JP2001513564A (ja) 2001-09-04
EP1019058B1 (en) 2006-05-24
PL192361B1 (pl) 2006-10-31
PL338828A1 (en) 2000-11-20
NO20000906L (no) 2000-02-24
PT1019058E (pt) 2006-08-31
AR083451A2 (es) 2013-02-27
JP3472261B2 (ja) 2003-12-02
YU9800A (sh) 2001-12-26
ATE326971T1 (de) 2006-06-15
SA98190680B1 (ar) 2006-04-04
US6172059B1 (en) 2001-01-09
CZ2000694A3 (cs) 2000-09-13
HK1027975A1 (en) 2001-02-02
TR200000490T2 (tr) 2000-08-21
NZ503414A (en) 2002-11-26
CN1197578C (zh) 2005-04-20
RS49808B (sr) 2008-08-07
CA2301646A1 (en) 1999-03-04
BG64337B1 (bg) 2004-10-29
WO1999009990A1 (en) 1999-03-04
HU226063B1 (hu) 2008-04-28
IL134185A (en) 2005-11-20
TW450812B (en) 2001-08-21
CL2008003111A1 (es) 2009-09-11
HUP0003093A2 (hu) 2001-08-28
DE69834655D1 (de) 2006-06-29
BR9811994A (pt) 2000-09-05
US6255481B1 (en) 2001-07-03
HRP980461A2 (en) 1999-06-30
AU8777198A (en) 1999-03-16
CA2301646C (en) 2008-11-18
UA44370C2 (uk) 2002-02-15
CY1105228T1 (el) 2010-03-03
NO20000906D0 (no) 2000-02-24
CN1268055A (zh) 2000-09-27
AU742761B2 (en) 2002-01-10
CZ290667B6 (cs) 2002-09-11
IL134185A0 (en) 2001-04-30
AR016869A1 (es) 2001-08-01
ES2265666T3 (es) 2007-02-16
BG104133A (bg) 2000-08-31
CO4970742A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
ID18500A (id) Suspensi pengurang gaya-hambat yang tak berair
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
ID22142A (id) Zat-zat pengikat-silang dari kain-kain selulosa
DE69839096D1 (de) Dispersion von cellulose
ATE386439T1 (de) Verwendungen von ölkörpern
DE59801135D1 (de) Federbeinlager
DE60008009D1 (de) Einzelradaufhängung
NO993453L (no) Vannbasert suspensjon til nasal administrering
DE69834090D1 (de) Kopfaufhängungseinheit
ID25535A (id) Komposisi batangan yang terdiri dari tetesan-tetesan pelunak yang terperangkap terdispersi padanya
ID29098A (id) Formulasi konsentrat suspensi yang mengandung pirimethanil
ATE289478T1 (de) Ektoparasitizide wässrige suspensionsformulierungen von spinosynen
NO981166L (no) Fremstilling av askorbylmonofosfater
ID22233A (id) Tablet telan yang terdiri dari parasetamol
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
ID24575A (id) Ekstraksi kontinyu dari poliamida
ID24217A (id) Ekstraksi kontinyu dari poliamida
DE69815165D1 (de) Aufhängungssystem
ID21650A (id) Suspensi farmasi yang terdiri dari nevirapin hemihidrat
ID24270A (id) Penghilang sumbatan keratotik
ID23086A (id) Formulasi suspensi berair dari pestisida terenkapsulasi
ID23885A (id) Bentuk-bentuk polimorf baru dari cypamfylline
ID23730A (id) Wadah segitiga yang terdiri dari bagian-bagian yang berbeda
BR9710127A (pt) Suspens o vitamínica
FI971745A0 (fi) Selkärangan dynaaminen malli